A phase I trial to evaluate the effect of Gemcabene on QT interval in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Gemcabene (Primary)
- Indications Hypercholesterolaemia; Hyperlipoproteinaemias; Hypertension; Hypertriglyceridaemia; Non-alcoholic steatohepatitis; Osteoarthritis
- Focus Adverse reactions
- 20 Apr 2017 New trial record